Kyverna Therapeutics Inc
(KYTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYTX | AZN | AMGN | GILD | BMY |
| Company | Kyverna Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 7.55 | 202.52 | 366.66 | 153.42 | 60.00 |
| High | 7.65 | 203.86 | 369.50 | 155.73 | 60.14 |
| Low | 7.35 | 202.10 | 365.18 | 152.60 | 59.25 |
| Latest | 7.55 | 203.75 | 367.11 | 152.64 | 59.87 |
| Change | unch | -1.01 | +0.53 | -3.16 | -0.06 |
| % Change | unch | -0.49% | +0.14% | -2.03% | -0.10% |
| Volume | 56,727 | 455,150 | 142,930 | 1,333,109 | 855,516 |
| 20-Day Average Volume | 812,937 | 4,491,945 | 3,104,771 | 8,437,787 | 13,057,857 |
| Previous Close | 7.55 | 204.76 | 366.58 | 155.80 | 59.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.45 | 188.69 | 351.52 | 140.41 | 56.82 |
| 20-Day Raw Stochastic | 5.91% | 94.78% | 71.09% | 87.59% | 69.55% |
| 20-Day Relative Strength | 44.94 | 63.84 | 60.69 | 68.56 | 62.52 |
| Weighted Alpha | +42.00 | +47.14 | +32.51 | +56.60 | +20.70 |
| Today's Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 48% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.89% since 02/05/26 | +8.74% since 02/05/26 | -0.27% since 02/05/26 | +2.28% since 02/05/26 | -0.10% since 02/05/26 |
| Low | 7.36 on 02/12/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 8.22 on 02/10/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -9.99% since 01/12/26 | +8.68% since 01/12/26 | +12.67% since 01/12/26 | +24.62% since 01/12/26 | +6.62% since 01/12/26 |
| Low | 7.21 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.54 on 01/21/26 |
| High | 10.55 on 01/22/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +1.06% since 11/12/25 | +16.06% since 11/12/25 | +9.07% since 11/12/25 | +23.81% since 11/12/25 | +21.15% since 11/12/25 |
| Low | 6.39 on 11/14/25 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 13.67 on 12/15/25 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +145.28% since 08/12/25 | +35.07% since 08/12/25 | +28.71% since 08/12/25 | +27.30% since 08/12/25 | +27.73% since 08/12/25 |
| Low | 2.95 on 08/13/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 13.67 on 12/15/25 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 330,660 | 317,563,904 | 197,396,352 | 193,297,952 | 122,002,680 |
| Shares Outstanding, K | 43,796 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -127,480,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -36,790,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 3.45 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.85 on 11/12/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 23.88 | 16.69 | 18.07 | 9.90 |